Gonadal Dysgenesis: Clinical Trials

149 trials for Gonadal Dysgenesis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

80 completed, 22 recruiting, 17 unknown, 9 active not recruiting. 21 Phase 2, 20 Phase 3, 16 Not applicable, 15 Phase 4, 5 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 221Completed 12, Active not recruiting 3, Not yet recruiting 2, Unknown 2, Enrolling by invitation 1, Withdrawn 1
Phase 320Completed 13, Active not recruiting 3, Recruiting 3, Not yet recruiting 1
Not applicable16Completed 6, Recruiting 3, Active not recruiting 2, Withdrawn 2, Enrolling by invitation 1, Not yet recruiting 1, Unknown 1
Phase 415Completed 11, Recruiting 4
Phase 15Completed 2, Active not recruiting 1, Recruiting 1, Terminated 1
Early Phase 11Unknown 1

Follow Gonadal Dysgenesis: new trials by email Literature Review of Gonadal Dysgenesis trials Research Report on Gonadal Dysgenesis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
SEMAFORCRANIO : Multicenter, Double-blind, Parallel, Randomized Controlled Trial of the Efficacy of Semaglutide in Hypothalamic Obesity Secondary to Craniopharyngioma in Children Aged 12 to 17 Years
Semaglutide (Wegovy) weekly injection, Placebo weekly Injection - Craniopharyngioma, Child
Phase 3Not yet recruitingUniversity Hospital, Angers502026-11-012026-09-29
Sexual Quality of Life in Female Patients With Lipodystrophy Syndromes or Turner's Syndrome: a Case-control Study
Lipodystrophy Congenital Generalized, Lipodystrophy, Familial Partial
Not yet recruitingAssistance Publique - Hôpitaux de Paris14162026-10-012026-09-02
Hematological Profile in Children With Numerical Chromosomal Disorders
Down Syndrome, Turner Syndrome
Not yet recruitingAssiut University1582026-09-022026-09-10
Pre-pubertal Low Dose Transdermal Estradiol in Turner Syndrome
Estradiol transdermal patch 0.025mg/24 hours- 1/8th fractionated patch - Turner Syndrome, Primary Ovarian Insufficiency
Phase 2Not yet recruitingChildren's National Research Institute152026-09-012026-08-25
The Efficacy and Safety of Inpegsomatropin Injection in Children With Turner Syndrome (TS) and Short Stature
Inpegsomatropin-Injection, Givopegsomatropin Solution Injection - Turner Syndrome
Phase 3RecruitingXiamen Amoytop Biotech Co., Ltd.842026-07-052026-07-22
A Multiple Baseline Feasibility Trial of Social Management Training for People With Sex Chromosome Aneuploidies
Social Management Training - Sex Chromosome Disorders
Phase 1RecruitingUniversity of Oslo302026-06-012026-07-22
A Study Comparing Different Treatment Approaches for the Initiation of Puberty in Girls With Turner Syndrome Using a TRIFECTA-DARED Approach for Rare Diseases
Oral estradiol valerate, Transdermal 17β estradiol - Turner Syndrome
Phase 2Not yet recruitingUniversiti Kebangsaan Malaysia Medical Centre242026-02-152026-02-02
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
Lonapegsomatropin [SKYTROFA®], Somatropin Pen Injector - Turner Syndrome, Short Stature Homeobox Gene Mutation
Phase 3RecruitingAscendis Pharma A/S1862025-12-122026-09-30
Parental Project Amongst 93 Patients With Turner Syndrome
Turner Syndrome
RecruitingUniversity Hospital, Strasbourg, France932025-11-182026-01-15
A Long-Term Study of Bivamelagon in Participants With Hypothalamic Obesity (HO)
Bivamelagon - Hypothalamic Obesity
Phase 2Enrolling by invitationRhythm Pharmaceuticals, Inc.252025-11-102026-02-10
A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)
Setmelanotide, Placebo - Hypothalamic Obesity, Multiple Pituitary Hormone Deficiency Genetic Form
Phase 3RecruitingRhythm Pharmaceuticals, Inc.392025-09-232026-02-12
Bleeding Patterns in Sequential and Continuous Progesterone Supplementation in Adolescents With Turner Syndrome
Micronized progesterone 200 MG, Micronized Progesterone 100 MG - Turner Syndrome, Primary Ovarian Insufficiency (Poi)
Phase 4RecruitingChildren's Mercy Hospital Kansas City402025-07-312026-08-25
Tirzepatide in PWS, HO and GNSO
Tirzepatide - Prader-Willi Syndrome, Hypothalamic Obesity
Phase 4RecruitingGrace Kim362025-05-012025-09-16
Implications of Maternal 45,X Mosaicism as a Secondary Genomic Finding Following Cell-Free DNA Sequencing During Pregnancy: A Deep Phenotype Study
Cardiovascular Phenotype, Metabolic Phenotype
WithdrawnEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)2025-04-012025-04-02
Efficacy and Safety of Phentermine/Topiramate in Youth With Hypothalamic Obesity
Phentermine / Topiramate Extended Release Oral Capsule [Qsymia], Placebo - Hypothalamic Obesity, Hypothalamic Tumor
Phase 2Active not recruitingSeattle Children's Hospital242025-03-012026-10-16
Genetic and Epigenetic Background of Inner Ear Dysfunction in Turner Syndrome
Sensorineural Hearing Loss, Turner Syndrome
RecruitingGødstrup Hospital1502025-02-012026-09-11
Characterization of Hepatopathy in Turner Syndrome: Analysis of Determinants
Turner Syndrome
RecruitingIRCCS Azienda Ospedaliero-Universitaria di Bologna1202025-01-072025-01-27
Growing up With the Young Endocrine Support System (YESS!)
YESS! game, Snake '97, Transition-toolkit - Congenital Adrenal Hyperplasia, Hypogonadotropic Hypogonadism
Not applicableNot yet recruitingdr. Laura C. G. de Graaff-Herder1602024-12-012023-09-07
Open-Label Extension Study of Setmelanotide
Setmelanotide - Obesity Associated With Defects in Leptin-melanocortin Pathway
Phase 3CompletedRhythm Pharmaceuticals, Inc.282024-10-212026-07-15
Clinical and Genetic Aspects in Fetuses and Children With Sex Chromosome Disorders
Sex Chromosome Disorders
Enrolling by invitationUniversity of Aarhus3002024-09-012026-01-14

Showing 20 of 149. Sign in to see all of them.

Narrower conditions

Turner Syndrome (124)  ·  Sexual Infantilism (23)  ·  Down Syndrome (14)  ·  Klinefelter Syndrome (14)  ·  Trisomy 18 Syndrome (13)  ·  Dwarfism, Pituitary (12)  ·  Genetic Diseases, Inborn (12)  ·  Trisomy 13 Syndrome (12)  ·  Dwarfism (10)  ·  Primary Ovarian Insufficiency (10)  ·  Craniopharyngioma (8)  ·  Hypogonadism (7)  ·  Sex Chromosome Aberrations (7)  ·  Noonan Syndrome (6)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (149)  ·  Female Urogenital Diseases (149)  ·  Female Urogenital Diseases and Pregnancy Complications (149)  ·  Gonadal Disorders (149)  ·  Male Urogenital Diseases (149)  ·  Urogenital Abnormalities (149)  ·  Urogenital Diseases (149)  ·  Congenital Abnormalities (148)  ·  Endocrine System Diseases (148)  ·  Disorders of Sex Development (146)  ·  Chromosome Disorders (125)  ·  Cardiovascular Abnormalities (124)  ·  Heart Diseases (123)  ·  Sex Chromosome Disorders of Sex Development (123)

Interventions

Human Growth Hormone (24)  ·  Growth Hormone (10)  ·  Estradiol (8)  ·  Exenatide (5)  ·  setmelanotide (4)  ·  Blood Specimen Collection (3)  ·  Estrogens (3)  ·  Oxandrolone (2)  ·  estradiol, estriol drug combination (2)  ·  lonapegsomatropin (2)  ·  somapacitan (2)  ·  Androgens (1)  ·  DNA, Ribosomal (1)  ·  Diagnostic Imaging (1)  ·  Diazoxide (1)

Sponsors

University of Aarhus (13)  ·  Novo Nordisk A/S (12)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (7)  ·  Rhythm Pharmaceuticals, Inc. (7)  ·  Natera, Inc. (6)  ·  Assistance Publique - Hôpitaux de Paris (5)  ·  Merck KGaA, Darmstadt, Germany (4)  ·  Eli Lilly and Company (3)  ·  Ferring Pharmaceuticals (3)  ·  Seattle Children's Hospital (3)  ·  University Hospital, Strasbourg, France (3)  ·  University of Colorado, Denver (3)  ·  dr. Laura C. G. de Graaff-Herder (3)  ·  Aarhus University Hospital (2)  ·  Changchun GeneScience Pharmaceutical Co., Ltd. (2)

Countries

United States (65)  ·  France (26)  ·  Denmark (19)  ·  Spain (13)  ·  United Kingdom (13)  ·  Netherlands (11)  ·  Germany (10)  ·  Italy (10)  ·  South Korea (9)  ·  Canada (8)  ·  China (6)  ·  Belgium (5)  ·  Sweden (5)  ·  Czechia (4)  ·  Ireland (4)

Top investigators

David Meeker, MD (6)  ·  Barbara Lippe, M.D. (2)  ·  Christian Trolle, MD (2)  ·  Claus H Gravholt, MD (2)  ·  Claus H Gravholt, Professor (2)  ·  Imen Mehri Turki (2)  ·  Nelly Mauras, MD (2)  ·  Peer Dar, MD (2)  ·  Shana E McCormack, MD (2)  ·  Veronica Gomez-Lobo, M.D. (2)

Results publications

PMID 36978128, PMID 10417280, PMID 10518081, PMID 10599727, PMID 10599729, PMID 11531930, PMID 12466334, PMID 12629094, PMID 12820840, PMID 15784709, PMID 15900109, PMID 16757526, PMID 16814942, PMID 17535868, PMID 17875973, PMID 19699898, PMID 20375405, PMID 20733274, PMID 21294891, PMID 21310373, PMID 21398400, PMID 21406078, PMID 21449786, PMID 21519036, PMID 21619701, PMID 21880799, PMID 21982653, PMID 22005709, PMID 22104675, PMID 22281937, PMID 22464072, PMID 22508317, PMID 22617594, PMID 22742782, PMID 22788856, PMID 23215555, PMID 23444191, PMID 23567489, PMID 23613152, PMID 23658497, PMID 23678038, PMID 23712453, PMID 23737664, PMID 23936059, PMID 24135152, PMID 24388429, PMID 24571752, PMID 24762109, PMID 24785862, PMID 24923356

NIH funding

UL1TR001082 (2), 2004 (1), 2008 (1), 2009 (1), 268201000048C-5-0-1 (1), K01MH083045 (1), N01HV681997 (1), R44HD062114 (1), UL1TR000077 (1)